Lantheus Holdings (LNTH) Non Operating Income (2014 - 2026)
Lantheus Holdings (LNTH) reported Non Operating Income of $5.7 million for Q1 2026, down 59.58% year-over-year from $14.1 million in Q1 2025, and up 124.5% quarter-over-quarter from -$23.3 million in Q4 2025.
Lantheus Holdings (LNTH) Non Operating Income (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Non Operating Income data on file, last reported at $5.7 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $5.7 million, down 59.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.1 million (down 119.14% YoY), and the FY2025 annual result was $271000.0, down 99.27% from the prior year.
- Non Operating Income improved to $5.7 million in Q1 2026 per LNTH's latest filing, from -$23.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $52.6 million in Q3 2023 and troughed at -$60.2 million in Q4 2023.
- A 5-year average of $2.4 million and a median of $4.5 million in 2023 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 4881.93% in 2023 and fell as far as 4211.67% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$1.4 million in 2022, then tumbled by 4211.67% to -$60.2 million in 2023, then surged by 115.68% to $9.4 million in 2024, then sank by 346.75% to -$23.3 million in 2025, then surged by 124.5% to $5.7 million in 2026.
- Business Quant data shows LNTH's Non Operating Income at $5.7 million in Q1 2026, -$23.3 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 6.90 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 9.95 Mn |
| Jun 30, 2024 | 9.04 Mn |
| Mar 31, 2024 | 8.79 Mn |
| Dec 31, 2023 | -60.23 Mn |
| Sep 30, 2023 | 52.65 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | 310,000.00 |
| Mar 31, 2022 | 485,000.00 |
| Dec 31, 2021 | -4.14 Mn |
| Sep 30, 2021 | -3.94 Mn |
| Jun 30, 2021 | 182,000.00 |